Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 2.810
-0.140 (-4.75%)
Sep 25, 2026, 4:10 PM AEST
Mayne Pharma Group Market Cap
Mayne Pharma Group has a market cap or net worth of 228.3 million as of September 25, 2026. Its market cap has decreased by -43.80% in one year.
Market Cap
228.30M
Enterprise Value
191.49M
Revenue
383.68M
Ranking
n/a
PE Ratio
10.37
Stock Price
2.81
ChartMarket Cap Chart
Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 228.30M, an increase of 400.01%. That is a compound annual growth rate of 8.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 228.30M | -9.65% |
| Dec 31, 2025 | 252.67M | -37.42% |
| Dec 31, 2024 | 403.79M | -19.19% |
| Dec 29, 2023 | 499.66M | 43.60% |
| Dec 30, 2022 | 347.96M | -33.16% |
| Dec 31, 2021 | 520.63M | -10.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 85.78B |
| Sigma Healthcare | 29.68B |
| Pro Medicus | 17.10B |
| Ramsay Health Care | 12.81B |
| Monash IVF Group | 292.23M |
| Healius | 261.42M |
| BLS Pharmaceuticals | 244.12M |
| Paragon Care | 231.74M |